Related Experiment Video
Updated: Jul 8, 2026

Video Imaging and Spatiotemporal Maps to Analyze Gastrointestinal Motility in Mice
Published on: February 3, 2016
Constipation outcomes in children with and without autism spectrum disorder: Insights from a tertiary motility
Umair Khalid1, Rishi Bolia1,2, Joshua Bunt3
1Department of Gastroenterology, Hepatology and Liver Transplant, Queensland Children's Hospital, Brisbane, Queensland, Australia.
Insights
Children with autism spectrum disorder (ASD) have worse constipation outcomes and lower treatment adherence than peers without ASD. Autism severity did not significantly impact constipation prognosis in this study.
Area of Science:
- Pediatric Gastroenterology
- Neurodevelopmental Disorders
- Clinical Outcomes Research
Background:
- Autism spectrum disorder (ASD) frequently co-occurs with chronic constipation, posing a significant clinical challenge.
- Limited comparative data exists on constipation management and outcomes in children with and without ASD, or across ASD severity levels.
Purpose of the Study:
- To compare constipation outcomes at 1-year and last follow-up between children with and without ASD.
- To evaluate the influence of ASD severity on constipation prognosis.
Main Methods:
- Retrospective analysis of 196 children with chronic constipation managed in a tertiary motility service.
- Extracted data included demographics, comorbidities, adherence, interventions, and outcomes.
- Subgroup analyses assessed outcomes across ASD severity levels; statistical comparisons used Chi-square, Mann-Whitney U, and Kruskal-Wallis tests (p < 0.05).
Main Results:
- The ASD cohort (n=74) showed higher male prevalence, lower medication adherence (56.8% vs. 76.2%), and poorer constipation resolution (11% vs. 25%) compared to the non-ASD group (n=122).
- Attention deficit hyperactivity disorder (ADHD) was significantly more prevalent in the ASD group (50% vs. 13.9%).
- Constipation outcomes and compliance were generally similar across ASD severity levels, with lowest toileting compliance noted in Level 3.
Conclusions:
- Children with ASD experience poorer constipation resolution and lower treatment adherence compared to non-ASD children.
- ASD severity did not significantly alter constipation outcomes, suggesting a need for tailored interventions.
- Multidisciplinary strategies are essential to improve adherence and optimize outcomes for children with ASD and chronic constipation.
Objectives:
Autism spectrum disorder (ASD) is commonly associated with gastrointestinal comorbidities, particularly chronic constipation. Despite high clinical burden and frequent tertiary referrals, comparative data describing clinical characteristics, management and outcomes between children with and without ASD-and across ASD severity levels-remain limited. This study compared constipation outcomes at 1 year and the most recent follow-up between children with and without ASD and assessed whether autism severity influenced prognosis.
Methods:
We retrospectively analysed children with chronic constipation managed through a tertiary motility service and enrolled as of 31 January 2024. Demographics, comorbidities, adherence, interventions and outcomes were extracted. Subgroup analyses examined outcomes across ASD severity levels. Statistical comparisons used Chi-square, Mann-Whitney U and Kruskal-Wallis tests, with significance defined as p < 0.05.
Results:
Among 196 children, 74 (37.7%) had ASD and 122 (62.2%) did not. The ASD cohort had more males (62.2% vs. 45.9%, p = 0.038), lower medication adherence (56.8% vs. 76.2%, p = 0.006) and lower constipation resolution at last follow-up (11% vs. 25%, p = 0.036). Attention deficit hyperactivity disorder (ADHD) was more prevalent in the ASD group (50% vs. 13.9%, p = 0.0001). Across ASD severity levels, outcomes, compliance, and therapy needs were broadly similar, though toileting compliance tended to be lowest in Level 3.
Conclusions:
Children with ASD demonstrate lower treatment adherence and poorer constipation resolution compared with non-ASD peers. Outcomes across ASD severity levels are largely similar. Targeted, multidisciplinary strategies are needed to address adherence and optimise outcomes in this high-risk group.
Related Concept Videos
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Assessment of the Rectum and Anus
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Gastrointestinal Motility Disorders
Drugs for Treatment of Constipation-Predominant IBS
Irritable Bowel Syndrome III: Medical and Nursing Management